Angeion Corp. (ANGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Angeion Corp. (ANGN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jean who wrote (990)	2/23/1999 7:40:00 PM
From: ewolf	Read Replies (1) of 1046

Sorry that you won't be able to participate in the conference call. Keeping my day job now seems like a good idea... Angeion has delivered on the development side. Whether they can actually achieve market share is what matters now. They anticipate getting the 2030 approved in a fairly narrow time frame and we may see approval for 2020 next week. I'd like to know where they think they can get money and what makes them optimistic about selling their products. I really thought the lawsuit would be settled because Angeion had a strong position that they would trade for less cash than Guidant might pay in a court battle. Often wondered whether jandj or even bsx might be interested in getting into the defib market quickly with the purchase of angeion. What would make Angeion a viable investment for those companies? What keeps them away? Are they waiting to see if CPI's claim against Angeion is dismissed? Wouldn't a small operation like angeion be significantly easier to absorb than Stj's defib business? Hope tomorrow's call provides positive answers. In retrospect, it sounds so sensible that even small success against mdt and gdt was a monumental task not likely to happen. later, eaw

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next